[144] Axogen, Inc. SEC Filing

Rhea-AI Filing Summary

Axogen, Inc. (AXGN) submitted a Form 144 notice reporting a proposed sale of 736 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $13,248.80 and an approximate sale date of 10/06/2025 on NASDAQ. The filer reports the shares were acquired in an open market purchase on 08/24/2023 and fully paid in cash.

The filing also discloses multiple recent sales by related parties within the prior days: four transactions on 10/02/2025 and 10/03/2025 totaling 36,264 shares with combined gross proceeds shown. The filing includes standard attestations about material nonpublic information and Rule 10b5-1 trading-plan references but provides no additional commentary or financial results.

Positive

• Proposed sale is small: 736 shares versus 46,012,574 shares outstanding
• Shares to be sold were acquired on 08/24/2023 in an open-market purchase and paid in cash

Negative

• Multiple related-party sales reported on 10/02/2025 and 10/03/2025 totaling 36,264 shares
• Recent related-party disposals generated significant gross proceeds (individual proceeds shown up to $267,073.56)

Insights

Securities Attorney

TL;DR: Routine Rule 144 notice describing a small proposed sale and recent related-party dispositions.

The notice documents a proposed sale under Rule 144 of 736 common shares valued at $13,248.80, acquired in an open-market purchase on 08/24/2023. The form includes the required representations about absence of undisclosed material information and mentions Rule 10b5-1 mechanics where applicable.

Risks are procedural: ensure the seller meets holding-period and public-information conditions before sale. Watch for any subsequent amendments or Form 4 filings within days after 10/06/2025 that would confirm execution or show different volumes.

Equity Market Analyst

TL;DR: The sale size is small versus total shares outstanding, but related-party selling over consecutive days may merit monitoring.

The proposed sale of 736 shares is small against the reported 46,012,574 shares outstanding and is unlikely by itself to affect market supply materially. However, the filing lists four recent related-party sales on 10/02/2025 and 10/03/2025 totaling 36,264 shares with material gross proceeds figures recorded.

Investors may monitor short-term trading around 10/06/2025 and any issuer disclosures explaining concentrated insider or trust selling; absent additional disclosures, the events appear as liquidity actions rather than operational signals.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	736	13248.80	46012574	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/24/2023	Open Market Purchase	Issuer			736	08/24/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Elizabeth J Burke 2024 Irrevocable Trust 13631 Progress Blvd Suite 400 Alachua FL 32615	Common	10/02/2025	2400	43224.00
Elizabeth J Burke 2024 Irrevocable Trust 13631 Progress Blvd Suite 400 Alachua FL 32615	Common	10/03/2025	11307	206316.82
William P. Burke 13631 Progress Blvd Suite 400 Alachua FL 32615	Common	10/03/2025	14937	267073.56
William P. Burke 13631 Progress Blvd Suite 400 Alachua FL 32615	Common	10/02/2025	7620	136169.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Axogen's (AXGN) Form 144 report?

It reports a proposed sale of 736 common shares valued at $13,248.80 with an approximate sale date of 10/06/2025 on NASDAQ.

When were the shares being sold originally acquired?

The shares were acquired in an open-market purchase on 08/24/2023 and paid for in cash.

Are there other recent sales disclosed in the filing for AXGN?

Yes. The filing lists four sales on 10/02/2025 and 10/03/2025 totaling 36,264 shares with combined gross proceeds reported.

Which broker is handling the proposed sale?

The broker named is Fidelity Brokerage Services LLC located in Smithfield, RI.

Does the filing state any material nonpublic information?

The signer represents they do not know any undisclosed material adverse information; no specific material nonpublic facts are disclosed in the filing.